Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Buy dildos and vibrators.
Popular Articles

Editorial, Opinion Piece Respond To Closure Of Murdered Abortion Provider Tiller's Clinic
Two newspapers recently published an editorial and an opinion piece in reaction to the announcement that murdered Kansas abortion provider George Tiller"s Wichita clinic would be permanently closed. The clinic was one of a handful in the U.S. offering abortion procedures in the second and third trimesters. Summaries appear below.~ Kansas City Star: The closing of Tiller"s clinic is "a tragedy for American democracy," and the "irrational violence" of his death has "trumped public policy," a Star editorial states. "The basis of civilization is that we agree to submit to the rule of law in order for society to flourish," the editorial says, adding that Tiller"s murder is "antithetical to that principle. It is dismaying to see a killer achieve his objective." The editorial notes that Tiller provided abortion services in "tragic cases" involving women "at risk of infertility or death; fetuses with severe abnormalities; and victims of rape and incest." It continues that the "reduction or loss of that service will create hardships and may put women"s lives at risk." Hospitals and doctors who refer such cases to abortion providers "must reassess the circumstances under which they would perform late-term abortions," according to the editorial. In addition, the "medical profession must take a role in training and supporting doctors willing to provide abortions," and the government and local police "must do all they can to protect a legal medical practice," the editorial says. It concludes, "Democracy demands that we not allow murder to make de facto public policy" (Kansas City Star, 6/11).~ Eric Zorn, Chicago Tribune: The announcement that Tiller"s clinic will remain permanently closed "was simply more proof that violence and intimidation can get results where civil discourse and political process fail," Tribune columnist Zorn writes. "The question isn"t whether prominent foes of abortion rights are being honest with us when they decry Tiller"s violent death and express regret over the means used to achieve an end they"ve sought," Zorn writes, adding, "Some are, I"m sure." He continues that abortion-rights opponents "recognize that ... a movement calling itself "pro-life"can"t also be pro-murder" and "are politically savvy enough to know that the gains won by terrorist acts are grudging and difficult to sustain." He continues that to "make terrorism less effective, and thereby discourage it," abortion-rights advocates, the medical profession, politicians and law enforcement officials "need to reopen that clinic in Wichita and assure its safe operation ... to defy terrorism, if for no other reason." He concludes that "as long as abortion remains legal, this same coalition needs to strive to expand the number of facilities where it"s available" (Zorn, Chicago Tribune, 6/11).
buy viagra
Shedding Light On Social Brain Development
The capacity to figure out what others are thinking and what they mean is an ability unique to people that"s central to our lives. A new study on the neural mechanisms that govern these abilities sheds light on the relation between how people and groups interact, on the one hand, and how the brain develops and functions, on the other.
News of the day
Kennedy Plan Skips Contentious Issues, Still Angers GOP
The first detailed health reform proposal "got off to a rocky start Tuesday," as "even moderate Republicans" attacked a draft bill by Sen. Edward Kennedy, D-Mass., and Democrats from his Health, Education, Labor and Pensions Committee, the Los Angeles Times reports. Many of the proposals goals are "broadly shared by lawmakers of both parties," but GOP legislators complained they were excluded from the drafting process and that the Democrats are rushing reform.
Endocrinology

Quantum Immunologics, A Major Mentor Capital Investee, Starts FDA-Authorized Breast Cancer Trials

Mentor Capital, Inc. (Pink Sheets:MNTR) announces that Quantum Immunologics, Inc. (QI) has met a significant milestone marking the beginning of its FDA-authorized breast cancer trial, the completion of the first clinical treatment injection. Mentor Capital, Inc. is the largest single shareholder in QI and looks to provide equity funding throughout the trials, assist QI in funding future strategic stock or cash acquisitions, and to stand by as a preferred funding for QI during later stage or additional trials. Calculated at the current QI private placement price, Mentor Capital holds approximately $3.74 in QI stock per Mentor share, and QI represents the majority of Mentor Capital"s portfolio assets. Quantum Immunologics is based in Tampa, Florida and focuses on cancer immunotherapies. This research and development company is currently sponsoring and conducting an FDA-authorized Phase I/II clinical trial testing the safety and efficacy of its immunotherapy on twenty-seven Stage IV breast cancer patients who have failed conventional therapy. The first patient in the breast cancer trial has begun to receive QI"s dendritic cell therapy. According to Mr. Chuck Broes, CEO of QI, "This achievement marks a significant milestone in the life cycle of our company, and we look forward with great hope and commitment as we aspire to a successful trial outcome." Chet Billingsley, CEO of Mentor Capital, adds, "The successful initiation of concurrent Phase I/II trials represents an important step in the value equation for QI. Comparing the cost to acquire 20% of other dendritic immunotherapy companies, like Dendreon (DNDN), with Mentor Capital, which holds 20% of QI, will reveal attractive buying opportunities for biotechnology investors, now that QI is at the clinical stage." QI"s clinical trial is designed around the use of QI"s proprietary dendritic cell therapy, which employs oncofetal antigen (OFA) to recruit the patient"s own immune system to target and attack the cancer cells with the intent to improve patient survivability and quality of life. Each patient will receive three monthly injections of the patient"s own dendritic cells that have been sensitized to OFA. It is anticipated that once the sensitized cells are injected back into the patient, the patient"s T-cells will locate the OFA found on the patient"s cancer cells, thereby generating an immune response with the goal of killing the cancer cells and preventing further spread of the disease. Further information on Quantum Immunologics, including a summarizing video of the QI breast cancer treatment methodology that is now in FDA trials, may be found at their company web site: http://www.QuantumImmunologics.com. Comprehensive information on Mentor Capital, including capital structure detail, can be found at: http://www.MentorCapital.com. Level II quotes, news, financial information and trading charts may be referenced at http://www.PinkSheets.comunder the trading symbol MNTR. Quantum Immunologics


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009